Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alex Gammerman

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
IEEE Transactions on Information Technology in Biomedicine : a Publication of the IEEE Engineering in Medicine and Biology Society|November 11, 2010
Reliable confidence measures for medical diagnosis with evolutionary algorithmsAntonis Lambrou, Harris Papadopoulos, Alex Gammerman
Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing|December 17, 2011
Determining confidence of predicted interactions between HIV-1 and human proteins using conformal methodIlia Nouretdinov, Alex Gammerman, Yanjun Qi, et al.
International Journal of Neural Systems|September 28, 2005
Qualified predictions for microarray and proteomics pattern diagnostics with confidence machinesTony Bellotti, Zhiyuan Luo, Alex Gammerman, et al.
Statistical Applications in Genetics and Molecular Biology|August 5, 2008
Clinical mass spectrometry proteomic diagnosis by conformal predictorsAlex Gammerman, Ilia Nouretdinov, Brian Burford, et al.
Breast Cancer Research : BCR|March 10, 2011
Autoantibodies to aberrantly glycosylated MUC1 in early stage breast cancer are associated with a better prognosisOla Blixt, Deanna Bueti, Brian Burford, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2008
Predicting clinical outcome in patients diagnosed with synchronous ovarian and endometrial cancerSusan J Ramus, Karim Elmasry, Zhiyuan Luo, et al.
Clinical Chemistry|February 17, 2007
Preanalytic influence of sample handling on SELDI-TOF serum protein profilesJohn F Timms, Elif Arslan-Low, Aleksandra Gentry-Maharaj, et al.
Clinical Chemistry|January 23, 2010
Peptides generated ex vivo from serum proteins by tumor-specific exopeptidases are not useful biomarkers in ovarian cancerJohn F Timms, Rainer Cramer, Stephane Camuzeaux, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 5, 2011
Highly accurate detection of ovarian cancer using CA125 but limited improvement with serum matrix-assisted laser desorption/ionization time-of-flight mass spectrometry profilingAli Tiss, John F Timms, Celia Smith, et al.
Cancer Genomics & Proteomics|November 17, 2011
Early detection of ovarian cancer in samples pre-diagnosis using CA125 and MALDI-MS peaksJohn F Timms, Usha Menon, Dmitry Devetyarov, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
IEEE Transactions on Information Technology in Biomedicine : a Publication of the IEEE Engineering in Medicine and Biology Society|November 11, 2010
Reliable confidence measures for medical diagnosis with evolutionary algorithmsAntonis Lambrou, Harris Papadopoulos, Alex Gammerman
Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing|December 17, 2011
Determining confidence of predicted interactions between HIV-1 and human proteins using conformal methodIlia Nouretdinov, Alex Gammerman, Yanjun Qi, et al.
International Journal of Neural Systems|September 28, 2005
Qualified predictions for microarray and proteomics pattern diagnostics with confidence machinesTony Bellotti, Zhiyuan Luo, Alex Gammerman, et al.
Statistical Applications in Genetics and Molecular Biology|August 5, 2008
Clinical mass spectrometry proteomic diagnosis by conformal predictorsAlex Gammerman, Ilia Nouretdinov, Brian Burford, et al.
Breast Cancer Research : BCR|March 10, 2011
Autoantibodies to aberrantly glycosylated MUC1 in early stage breast cancer are associated with a better prognosisOla Blixt, Deanna Bueti, Brian Burford, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2008
Predicting clinical outcome in patients diagnosed with synchronous ovarian and endometrial cancerSusan J Ramus, Karim Elmasry, Zhiyuan Luo, et al.
Clinical Chemistry|February 17, 2007
Preanalytic influence of sample handling on SELDI-TOF serum protein profilesJohn F Timms, Elif Arslan-Low, Aleksandra Gentry-Maharaj, et al.
Clinical Chemistry|January 23, 2010
Peptides generated ex vivo from serum proteins by tumor-specific exopeptidases are not useful biomarkers in ovarian cancerJohn F Timms, Rainer Cramer, Stephane Camuzeaux, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 5, 2011
Highly accurate detection of ovarian cancer using CA125 but limited improvement with serum matrix-assisted laser desorption/ionization time-of-flight mass spectrometry profilingAli Tiss, John F Timms, Celia Smith, et al.
Cancer Genomics & Proteomics|November 17, 2011
Early detection of ovarian cancer in samples pre-diagnosis using CA125 and MALDI-MS peaksJohn F Timms, Usha Menon, Dmitry Devetyarov, et al.
Pageof 2